EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 90 pce

7680686920064 CH-68692 C10BA06 07.12.0.

Reimbursement limitations:

EZET_ROS_SAN

EZETIMIB ROSUVASTATIN SANDOZ est indiqué comme traitement substitutif chez le patient adulte qui reçoit déjà …

EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 90 pce
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 90 pce
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 90 pce
1 / 3
google

Details

Product number
6869203
CPT
-
Packaging group
90
Unit
mg
Composition
ezetimibum 10 mg, rosuvastatinum 20 mg ut rosuvastatinum calcicum, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum K 29-32, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, talcum, macrogola, E 172 (flavum), pro compresso obducto corresp. natrium 1.669 mg.

Articles (1)

Ezetimib Rosuvastatin Sandoz 10 mg / 20 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/02/2025
Patient information leaflet
Français
11/02/2025
Patient information leaflet
Italien
11/02/2025
Professional SmPC
Allemand
11/02/2025
Professional SmPC
Français
11/02/2025
Professional SmPC
Italien
11/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
200.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
1.669 MG Substance HBESI

Reimbursement information

Public price
CHF 81.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
68692
Drug name
Ezetimib Rosuvastatin Sandoz, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
03/02/2023
Authorization expiration date
02/02/2028
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 90 pce
Description (DE)
EZETIMIB ROSUVA Sandoz Filmtabl 10 mg/20 mg 90 Stk
Market launch
03/02/2023
Narcotic (BTM)
No

Other packaging sizes

EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 30 pce
30 MG
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 90 pce
90 MG
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/10 mg 30 pce
30 MG
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/10 mg 90 pce
90 MG
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 30 pce
30 MG
View